70 research outputs found

    Cryo-FIB Machining: An Alternative to TEM Cryo-Sections Cut with Diamonds?

    Get PDF
    Extended abstract of a paper presented at Microscopy and Microanalysis 2011 in Nashville, Tennessee, USA, August 7-August 11, 201

    Nuclear DDX3 expression predicts poor outcome in colorectal and breast cancer

    Get PDF
    Purpose: DEAD box protein 3 (DDX3) is an RNA helicase with oncogenic properties that shuttles between the cytoplasm and nucleus. The majority of DDX3 is found in the cytoplasm, but a subset of tumors has distinct nuclear DDX3 localization of yet unknown biological significance. This study aimed to evaluate the significance of and mechanisms behind nuclear DDX3 expression in colorectal and breast cancer. Methods: Expression of nuclear DDX3 and the nuclear exporter chromosome region maintenance 1 (CRM1) was evaluated by immunohistochemistry in 304 colorectal and 292 breast cancer patient samples. Correlations between the subcellular localization of DDX3 and CRM1 and the difference in overall survival between patients with and without nuclear DDX3 were studied. In addition, DDX3 mutants were created for in vitro evaluation of the mechanism behind nuclear retention of DDX3. Results: DDX3 was present in the nucleus of 35% of colorectal and 48% of breast cancer patient samples and was particularly strong in the nucleolus. Nuclear DDX3 correlated with worse overall survival in both colorectal (hazard ratio [HR] 2.34, P<0.001) and breast cancer (HR 2.39, P=0.004) patients. Colorectal cancers with nuclear DDX3 expression more often had cytoplasmic expression of the nuclear exporter CRM1 (relative risk 1.67, P=0.04). In vitro analysis of DDX3 deletion mutants demonstrated that CRM1-mediated export was most dependent on the N-terminal nuclear export signal. Conclusion: Overall, we conclude that nuclear DDX3 is partially CRM1-mediated and predicts worse survival in colorectal and breast cancer patients, putting it forward as a target for therapeutic intervention with DDX3 inhibitors under development in these cancer types

    Killer cell proteases can target viral immediate-early proteins to control human cytomegalovirus infection in a noncytotoxic manner.

    No full text
    Human cytomegalovirus (HCMV) is the most frequent viral cause of congenital defects and can trigger devastating disease in immune-suppressed patients. Cytotoxic lymphocytes (CD8+ T cells and NK cells) control HCMV infection by releasing interferon-γ and five granzymes (GrA, GrB, GrH, GrK, GrM), which are believed to kill infected host cells through cleavage of intracellular death substrates. However, it has recently been demonstrated that the in vivo killing capacity of cytotoxic T cells is limited and multiple T cell hits are required to kill a single virus-infected cell. This raises the question whether cytotoxic lymphocytes can use granzymes to control HCMV infection in a noncytotoxic manner. Here, we demonstrate that (primary) cytotoxic lymphocytes can block HCMV dissemination independent of host cell death, and interferon-α/β/γ. Prior to killing, cytotoxic lymphocytes induce the degradation of viral immediate-early (IE) proteins IE1 and IE2 in HCMV-infected cells. Intriguingly, both IE1 and/or IE2 are directly proteolyzed by all human granzymes, with GrB and GrM being most efficient. GrB and GrM cleave IE1 after Asp398 and Leu414, respectively, likely resulting in IE1 aberrant cellular localization, IE1 instability, and functional impairment of IE1 to interfere with the JAK-STAT signaling pathway. Furthermore, GrB and GrM cleave IE2 after Asp184 and Leu173, respectively, resulting in IE2 aberrant cellular localization and functional abolishment of IE2 to transactivate the HCMV UL112 early promoter. Taken together, our data indicate that cytotoxic lymphocytes can also employ noncytotoxic ways to control HCMV infection, which may be explained by granzyme-mediated targeting of indispensable viral proteins during lytic infection

    Extracellular Granzyme K Modulates Angiogenesis by Regulating Soluble VEGFR1 Release From Endothelial Cells

    Get PDF
    Angiogenesis is crucial for normal development and homeostasis, but also plays a role in many diseases including cardiovascular diseases, autoimmune diseases, and cancer. Granzymes are serine proteases stored in the granules of cytotoxic cells, and have predominantly been studied for their pro-apoptotic role upon delivery in target cells. A growing body of evidence is emerging that granzymes also display extracellular functions, which largely remain unknown. In the present study, we show that extracellular granzyme K (GrK) inhibits angiogenesis and triggers endothelial cells to release soluble VEGFR1 (sVEGFR1), a decoy receptor that inhibits angiogenesis by sequestering VEGF-A. GrK does not cleave off membrane-bound VEGFR1 from the cell surface, does not release potential sVEGFR1 storage pools from endothelial cells, and does not trigger sVEGFR1 release via protease activating receptor-1 (PAR-1) activation. GrK induces de novo sVEGFR1 mRNA and protein expression and subsequent release of sVEGFR1 from endothelial cells. GrK protein is detectable in human colorectal tumor tissue and its levels positively correlate with sVEGFR1 protein levels and negatively correlate with T4 intratumoral angiogenesis and tumor size. In conclusion, extracellular GrK can inhibit angiogenesis via secretion of sVEGFR1 from endothelial cells, thereby sequestering VEGF-A and impairing VEGFR signaling. Our observation that GrK positively correlates with sVEGFR1 and negatively correlates with angiogenesis in colorectal cancer, suggest that the GrK-sVEGFR1-angiogenesis axis may be a valid target for development of novel anti-angiogenic therapies in cancer

    Electron Tomography Resolves a Novel Crystal Structure in a Binary Nanocrystal Superlattice

    No full text
    The self-assembly of different nanocrystals into a binary superlattice is of interest for both colloidal science and nanomaterials science. New properties may emerge from the interaction between the nanocrystal building blocks that are ordered in close contact in three dimensions. Identification of the superlattice structure including its defects is of key interest in understanding the electrical and optical properties of these systems. Transmission electron microscopy (TEM) has been very instrumental to reach this goal but fails for complex crystal structures and buried defects. Here, we use electron tomography to resolve the three-dimensional crystal structure of a binary superlattice that could not be resolved by TEM only. The structure with a [PbSe]6[CdSe]19 stoichiometry has no analogue in the atomic world. Moreover we will show how tomography can overcome the clouding effects of planar defects on structure identification by TEM

    Intra- and Interparticle Heterogeneities in Solid Activators for Single-Site Olefin Polymerization Catalysis as Revealed by Micro-Spectroscopy

    No full text
    Transition metal–zeolite composites are versatile catalytic materials for a wide range of industrial and lab-scale processes. Significant advances in fabrication and characterization of well-defined metal centers confined in zeolite matrixes have greatly expanded the library of available materials and, accordingly, their catalytic utility. In this review, we summarize recent developments in the field from the perspective of materials chemistry, focusing on synthesis, postsynthesis modification, (operando) spectroscopy characterization, and computational modeling of transition metal–zeolite catalysts

    Synthesis and characterization of {Mo72Fe30}-coated large hexagonal gibbsite Îł-Al(OH)3 platelets

    No full text
    The polyoxometalates or POMs (clusters comprising at least two metal and many oxygen atoms) have recently gained significant interest owing to their versatile architecture and especially their catalytic activities. Due to their high catalytic activity but low surface area, there is always a demand for making high surface area POMs. This work demonstrates the attachment of the anionic {Mo72Fe30} POMs to gibbsite nanoplatelets with a residual positive charge to form large surface area composites. The resulting composite reported here has been characterized using cryo-TEM imaging, EDX/STEM (elemental) analysis, ATR-IR spectroscopy, SAXS, electrophoretic mobility determination and XRD. The composite reported here could find application in catalysis

    Electron Tomography Resolves a Novel Crystal Structure in a Binary Nanocrystal Superlattice

    No full text
    The self-assembly of different nanocrystals into a binary superlattice is of interest for both colloidal science and nanomaterials science. New properties may emerge from the interaction between the nanocrystal building blocks that are ordered in close contact in three dimensions. Identification of the superlattice structure including its defects is of key interest in understanding the electrical and optical properties of these systems. Transmission electron microscopy (TEM) has been very instrumental to reach this goal but fails for complex crystal structures and buried defects. Here, we use electron tomography to resolve the three-dimensional crystal structure of a binary superlattice that could not be resolved by TEM only. The structure with a [PbSe]6[CdSe]19 stoichiometry has no analogue in the atomic world. Moreover we will show how tomography can overcome the clouding effects of planar defects on structure identification by TEM
    • …
    corecore